Nothing Special   »   [go: up one dir, main page]

ATE178336T1 - Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis - Google Patents

Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis

Info

Publication number
ATE178336T1
ATE178336T1 AT91304449T AT91304449T ATE178336T1 AT E178336 T1 ATE178336 T1 AT E178336T1 AT 91304449 T AT91304449 T AT 91304449T AT 91304449 T AT91304449 T AT 91304449T AT E178336 T1 ATE178336 T1 AT E178336T1
Authority
AT
Austria
Prior art keywords
bronchitis
treatment
therapeutic composition
treating bronchitis
therapeutic compound
Prior art date
Application number
AT91304449T
Other languages
English (en)
Inventor
Mitchell Glass
Joseph Campbell Williams
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ATE178336T1 publication Critical patent/ATE178336T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT91304449T 1990-05-24 1991-05-17 Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis ATE178336T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52865790A 1990-05-24 1990-05-24

Publications (1)

Publication Number Publication Date
ATE178336T1 true ATE178336T1 (de) 1999-04-15

Family

ID=24106599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91304449T ATE178336T1 (de) 1990-05-24 1991-05-17 Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis

Country Status (12)

Country Link
EP (1) EP0458537B1 (de)
JP (1) JPH04235133A (de)
AT (1) ATE178336T1 (de)
AU (1) AU648078B2 (de)
CA (1) CA2043107A1 (de)
DE (1) DE69131058T2 (de)
DK (1) DK0458537T3 (de)
ES (1) ES2129401T3 (de)
GR (1) GR3029726T3 (de)
IE (1) IE911698A1 (de)
IL (1) IL98200A0 (de)
ZA (1) ZA913920B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0458536T3 (da) * 1990-05-24 1998-10-19 Zeneca Ltd Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
DE10138294C5 (de) * 2001-08-10 2006-09-28 Db Netz Ag Verfahren und Vorrichtung zum Auswechseln eines Fahrdrahtes an einer Oberleitung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182906A1 (de) * 1984-06-14 1986-06-04 Cortech, Inc. Aus pyogenen bakterien hergestellte menschliche leukozyt-elastase-inhibitoren und deren reinigungsverfahren
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (de) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituierte Peptid-Derivate
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
DE68925923T2 (de) * 1988-06-10 1996-11-14 Merck & Co Inc Antigene der einzigen Spaltungsstelle von Fibrinogen durch Elastase
EP0369391A3 (de) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituierte Amide
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis

Also Published As

Publication number Publication date
DE69131058T2 (de) 1999-09-09
IL98200A0 (en) 1992-06-21
CA2043107A1 (en) 1991-11-25
JPH04235133A (ja) 1992-08-24
AU648078B2 (en) 1994-04-14
EP0458537B1 (de) 1999-03-31
ZA913920B (en) 1992-02-26
IE911698A1 (en) 1991-12-04
EP0458537A2 (de) 1991-11-27
DE69131058D1 (de) 1999-05-06
EP0458537A3 (en) 1992-07-08
GR3029726T3 (en) 1999-06-30
DK0458537T3 (da) 1999-10-18
AU7719491A (en) 1991-11-28
ES2129401T3 (es) 1999-06-16

Similar Documents

Publication Publication Date Title
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DE3781182D1 (de) Tamoxifen zur topischen verwendung.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
DE69304843D1 (de) Methode zur Behandlung von Haarausfall
DE69301750D1 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE68910061D1 (de) Behandlung von Fasern mit Acarizidverbindungen.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE69116216D1 (de) Verwendung von Squalene, Squalane oder deren Mischungen zur Herstellung einer abkühlenden Zusammensetzung zur örtlichen Behandlung von Verbrennungen
DE68906700D1 (de) Verwendung eines polypeptids zur herstellung einer zusammensetzung zur behandlung von pankreatitis.
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee